GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hugel Inc (XKRX:145020) » Definitions » Deferred Policy Acquisition Costs

Hugel (XKRX:145020) Deferred Policy Acquisition Costs


View and export this data going back to 2015. Start your Free Trial

What is Hugel Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Hugel (XKRX:145020) Business Description

Industry
Traded in Other Exchanges
N/A
Address
61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon, Gangwon, KOR, 24206
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.